PARP1 and pulmonary fibrosis: Briefly, we demonstrate that JNJ, a selective antagonist of the histamine H4R, exerts its anti-inflammatory and anti-fibrotic properties independently of PARP-1 signaling pathway, in an in vivo mouse model of bleomycin-induced lung fibrosis.